Status:
UNKNOWN
Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
Lead Sponsor:
Chonnam National University Hospital
Collaborating Sponsors:
Chosun University Hospital
Chonbuk National University Hospital
Conditions:
Stroke, Ischemic
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aims to investigate the effectiveness and safety of alpha-lipoic acid in patients with diabetes and ischemic stroke treated with reperfusion therapy.
Detailed Description
Despite significant advances in the prevention and treatment of stroke, it is still one of the leading causes of death and debilitating disease. Unfortunately, several neuroprotective strategies have ...
Eligibility Criteria
Inclusion
- Patients with acute ischemic stroke within 6 hours of symptom onset
- Patients with diabetes
- Patients who underwent reperfusion therapy (Intravenous t-PA or endovascular thrombectomy)
Exclusion
- Pre-existing disability (Modified Rankin Scale \>= 1)
- Patients with severe renal disease (GFR \<30 ml / min)
- Patients whose survival period is expected to be less than 12 months due to serious diseases such as terminal cancer or liver failure
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04041167
Start Date
August 1 2018
End Date
December 31 2021
Last Update
August 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chonnam National University Hospital
Gwangju, South Korea